New Vaccines
There are several vaccines, which are being developed right now( the table below is dated 2006)
| Product name | Producer | Vaccination against |
Stage of development |
| Clamydia trachomatis vaccine | Emergent Bio Solutions | Clamydia trachomatis | preclinical |
| Cholera Guard | Avant immunotherapeutics | Cholera | Phase 2b |
| CAIV-T | Medimmune | Influenza | Phase 3 |
| Influenza | Merck | Influenza | Phase 1 |
| Flu-Intradermal | Sanofi Pasteur | Influenza | Phase 2b |
| FluNsure | GlaxoSmithKline | Influenza | Phase 2, children |
| Haemophilus Influenza vaccine | Emergent Bio Solutions | Otitis media |
Phase 1 |
| HIV Vaccine |
Merck | HIV | Phase 2 |
| HPV Vaccine | Merck | HPV | Phase 2 |
| Group A strep Vaccine | Wyeth | Streptococci | preclinical |
| GBS Vaccine | Emergent Bio Solutions | GBS | Phase 1 |
| Meningitis B Vaccine | GlaxoSmithKline | Meningitis B | Phase 2 |
| Meningitis B Vaccine | Wyeth | Meningitis B | Phase 1 |
| Neisseria meningititis A/ C vaccine | GlaxoSmithKline | Meningitis A and C | Phase 2-3 |
| Numax | Medimmune | Infection of the lower respiratory tract |
Phase 3 |
| Pentacel | Sanofi Pasteur | Hib, DTaP, Polio | registererd |
| RSV-Impfung | Wyeth | RSV-Virus | preclinical |
| Salmonellen Vaccine | Avant Immunotherapeutics | Salmonella typhii | Phase 1 |
| Simplirix | GlaxoSmithKline | Herpes genitalis | Phase 3 |
| 26-valent Streptococci vaccine | GlaxoSmithKline | Streptococci group A |
Phase 1/2 |
| Streptokokkus pneumoniae | Medimmune | Pneumococcal diseases |
Phase 1 |
| Streptorix | GlaxoSmithKline | Streptococcus pneumoniae |
Phase 3 |
Vaccines in development 2010
| Producer | Product name |
Vaccination against |
Stage of development |
| Bavarian Nordic | Imvamune | Smallpox | Phase 3 |
| Bharat Biotech | 116E | Rotavirus | Phase 3 |
| Crucell | Flavimum | Yellow fever | Phase 3 |
| Dynavax |
Heplisav | Hepatitis B |
Phase 3 |
| GlaxoSmithKline | Next-gen flu vaccine | Inactivated influenza for the elderly | Phase 3 |
| Hib-MenCYTT | Neisseria meningitis groups C &Y disease & Haemophilus influenzae type b | Phase 3 | |
| Nimentrix | Neisseria meningitis groups A, C, W & Y disease prophylaxis | Phase 3 | |
| Merck | V503 | Cervical cancer, 9 valent | Phase 3 |
| Novartis | Menveo Infants | Meningitis | Phase 3 |
| Menveo Adolescent | Meningitis | Phase 3 | |
| Sanofi Pasteur | Pediacel EU | DTP, polio, Hib | Phase 3 |
| Menactra | Meningitis infant/toddler 9 - 12 months | Phase 3 | |
| Adacel | DTP ages 4 - 6 | Phase 3 | |
| Hexaxim | DTP, Hepatitis B, polio, Hib | Phase 3 | |
| IMOJEV | Japanese encephalitis | Phase 3 |
